Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hyatt Hotels Corporation (H) vs Novavax Inc (NVAX) Price & Performance

Hyatt Hotels CorporationTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Hyatt Hotels Corporation vs Novavax Inc — how do they compare? Hyatt Hotels Corporation trades at $172.22 (market cap $16.27B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Hyatt Hotels Corporation is far larger — about 12.4× Novavax Inc's market cap, and Hyatt Hotels Corporation pays a 0.35% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

HNVAX
Market Cap
$16.27B$1.31B
Sector
Consumer CyclicalHealth
52-Week High
$202.09$11.19
52-Week Low
$135.42$6.22
Enterprise Value
$20.17B$889.30M
Dividend Yield
0.35%

Returns comparison

Trailing returns across standard periods

About Hyatt Hotels Corporation

Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.

Read more on H

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX